Miromatrix Medical Inc. (MIRO) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Eden Prairie, MN, United States. El CEO actual es Jeffrey James Ross.
MIRO tiene fecha de IPO 2021-06-24, 76 empleados a tiempo completo, cotiza en el NASDAQ Capital Marke, una capitalización de mercado de $92.95M.
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
